Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy
Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema
Bahia Metals Announces C$1.2 Million Private Placement with Expected Full Participation by Strategic Investor
LaFleur Minerals Continues to Expand Swanson Gold Deposit Mineralization Near Surface and Along Strike with 2.52 g/t Au over 14.35 Metres